US5866344A
(en)
*
|
1991-11-15 |
1999-02-02 |
Board Of Regents, The University Of Texas System |
Antibody selection methods using cell surface expressed libraries
|
US20030036092A1
(en)
*
|
1991-11-15 |
2003-02-20 |
Board Of Regents, The University Of Texas System |
Directed evolution of enzymes and antibodies
|
US5585271A
(en)
*
|
1993-02-26 |
1996-12-17 |
Sapporo Breweries Ltd. |
Yeast agglutination genes and yeast containing them
|
US5766914A
(en)
*
|
1995-01-26 |
1998-06-16 |
Michigan State University |
Method of producing and purifying enzymes
|
EP1019435A4
(de)
*
|
1996-01-29 |
2001-12-12 |
Univ Georgetown |
Amplifizierung der wirksamkeit exprimierter rekombinanter proteine
|
US6696251B1
(en)
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
EP0879878A1
(de)
*
|
1997-05-23 |
1998-11-25 |
Quest International B.V. |
Bier und andere lichtempfindliche Getränke mit verbessertem Geschmackstabilität und Verfahren zu ihrer Herstellung
|
EP0916726A1
(de)
|
1997-11-13 |
1999-05-19 |
Rijksuniversiteit te Groningen |
Befestigungs-Substanzen an Mikroorganismen
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
EP0954978B1
(de)
|
1998-03-12 |
2011-11-30 |
VHsquared Limited |
Produkten die inaktivierte Hefen oder Schimmel enthalten, die auf ihrer Aussenoberfläche aktive Antikörper haben
|
ATE535154T1
(de)
|
1998-03-12 |
2011-12-15 |
Vhsquared Ltd |
Produkten die inaktivierte hefen oder schimmel enthalten, die auf ihrer aussenoberfläche aktive antikörper haben
|
CN1249079C
(zh)
*
|
1999-03-25 |
2006-04-05 |
瓦申泰克尼利南塔基马斯凯斯库斯公司 |
蛋白质的分配方法
|
CN100365125C
(zh)
*
|
2000-07-26 |
2008-01-30 |
韩国生命工学研究院 |
来源于酵母的新型细胞壁锚定蛋白及其基因和使用其的细胞表面表达系统
|
AU2002220275A1
(en)
*
|
2000-12-08 |
2002-06-18 |
The Board Of Trustees Of The University Of Illinois |
Mutated class ii major histocompatibility proteins
|
WO2002048193A2
(en)
*
|
2000-12-13 |
2002-06-20 |
Unilever N.V. |
Camelidae antibody arrays
|
JP4340068B2
(ja)
*
|
2001-04-19 |
2009-10-07 |
関西化学機械製作株式会社 |
細胞表層結合性タンパク質およびその利用
|
CN100513548C
(zh)
|
2001-06-11 |
2009-07-15 |
应用超微系统股份有限公司 |
将AcmA型蛋白质锚融合体与微生物细胞壁材料进行结合的改良方法
|
ATE434040T1
(de)
|
2001-10-01 |
2009-07-15 |
Dyax Corp |
Mehrkettige eukaryontische display-vektoren und deren verwendungen
|
WO2003064608A2
(en)
*
|
2002-01-25 |
2003-08-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Surface based translation system
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US8968730B2
(en)
|
2002-08-14 |
2015-03-03 |
Macrogenics Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8530627B2
(en)
*
|
2002-08-14 |
2013-09-10 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8187593B2
(en)
*
|
2002-08-14 |
2012-05-29 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8193318B2
(en)
*
|
2002-08-14 |
2012-06-05 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
CA2495251C
(en)
|
2002-08-14 |
2018-03-06 |
Macrogenics, Inc. |
Fc.gamma.riib-specific antibodies and methods of use thereof
|
US8946387B2
(en)
*
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8044180B2
(en)
*
|
2002-08-14 |
2011-10-25 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US7563600B2
(en)
|
2002-09-12 |
2009-07-21 |
Combimatrix Corporation |
Microarray synthesis and assembly of gene-length polynucleotides
|
US7960512B2
(en)
*
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
AU2004204494B2
(en)
*
|
2003-01-09 |
2011-09-29 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
ES2393555T3
(es)
|
2003-10-22 |
2012-12-26 |
Keck Graduate Institute |
Métodos para la síntesis de polipéptidos hetero-multiméricos en levaduras usando una estrategia de apareamiento haploide.
|
EP1689348B1
(de)
|
2003-12-05 |
2013-05-15 |
Children's Hospital Medical Center |
Oligosaccharid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
|
US7521542B2
(en)
|
2004-05-10 |
2009-04-21 |
Macrogenics, Inc. |
Humanized FcγRIIB-specific antibodies and methods of use thereof
|
AU2005335714B2
(en)
|
2004-11-10 |
2012-07-26 |
Macrogenics, Inc. |
Engineering Fc antibody regions to confer effector function
|
EP1674479A1
(de)
*
|
2004-12-22 |
2006-06-28 |
Memorial Sloan-Kettering Cancer Center |
Modulierung von Fc-gamma-Rezeptoren zur Optimierung einer Immunotherapie
|
US11254748B2
(en)
|
2005-04-15 |
2022-02-22 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
US9284375B2
(en)
|
2005-04-15 |
2016-03-15 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
ES2707152T3
(es)
|
2005-04-15 |
2019-04-02 |
Macrogenics Inc |
Diacuerpos covalentes y usos de los mismos
|
US9963510B2
(en)
|
2005-04-15 |
2018-05-08 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
EP1726650A1
(de)
*
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoklonale Antikörper und Einzelkettenantikörper Fragments gegen das zelloberflächen Prostataspezifische Membranantigen
|
JP2008546392A
(ja)
*
|
2005-06-17 |
2008-12-25 |
バイオレクシス ファーマシューティカル コーポレーション |
固定されたトランスフェリン融合タンパク質ライブラリー
|
WO2007009082A1
(en)
*
|
2005-07-12 |
2007-01-18 |
Codon Devices, Inc. |
Compositions and methods for biocatalytic engineering
|
EP1746103A1
(de)
*
|
2005-07-20 |
2007-01-24 |
Applied NanoSystems B.V. |
Bifunktionelle Protein-Anker
|
DK2573114T3
(en)
|
2005-08-10 |
2016-07-04 |
Macrogenics Inc |
The identification and production of antibodies with variant Fc regions, and methods of using same
|
CA2644903A1
(en)
*
|
2006-03-10 |
2007-09-20 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant heavy chains and methods of using same
|
US20070231805A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Baynes Brian M |
Nucleic acid assembly optimization using clamped mismatch binding proteins
|
EP1918302A3
(de)
*
|
2006-05-18 |
2009-11-18 |
AvantGen, Inc. |
Verfahren zur Identifikation und Isolation von epitopspezifischen Antikörpern
|
EP2021029B1
(de)
|
2006-05-26 |
2014-06-11 |
MacroGenics, Inc. |
Humanisierte fc-gamma-riib-spezifische antikörper und verfahren zu ihrer anwendung
|
EP2032159B1
(de)
|
2006-06-26 |
2015-01-07 |
MacroGenics, Inc. |
Kombination aus fcgammariib-antikörpern und cd20-spezifischen antikörpern sowie verwendungsverfahren dafür
|
ES2599319T3
(es)
|
2006-06-26 |
2017-02-01 |
Macrogenics, Inc. |
Anticuerpos específicos de Fc RIIB y métodos de uso de éstos
|
US20080112961A1
(en)
*
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
WO2008140603A2
(en)
|
2006-12-08 |
2008-11-20 |
Macrogenics, Inc. |
METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
|
JP5492563B2
(ja)
|
2006-12-12 |
2014-05-14 |
バイオレクシス ファーマシューティカル コーポレーション |
トランスフェリン融合タンパク質ライブラリー
|
US20110076752A1
(en)
*
|
2007-02-09 |
2011-03-31 |
Medimmune, Llc |
Antibody library display by yeast cell plasma membrane
|
JP5754135B2
(ja)
|
2007-03-26 |
2015-07-29 |
アジェナス インコーポレイテッド |
関心対象のタンパク質の細胞表面ディスプレイ、スクリーニング、および産生
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
BRPI0816785A2
(pt)
|
2007-09-14 |
2017-05-02 |
Adimab Inc |
bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas
|
US8637435B2
(en)
*
|
2007-11-16 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Eukaryotic cell display systems
|
KR20190045414A
(ko)
|
2007-11-30 |
2019-05-02 |
애브비 바이오테크놀로지 리미티드 |
단백질 제형 및 이의 제조방법
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
US8795667B2
(en)
|
2007-12-19 |
2014-08-05 |
Macrogenics, Inc. |
Compositions for the prevention and treatment of smallpox
|
CA2715212A1
(en)
|
2008-03-03 |
2009-09-11 |
Glycofi, Inc. |
Surface display of recombinant proteins in lower eukaryotes
|
ITUD20080055A1
(it)
*
|
2008-03-13 |
2009-09-14 |
Transactiva S R L |
Procedimento per la produzione di una proteina umana in pianta, in particolare un enzima lisosomiale umano ricombinante in endosperma di cereali
|
EP3045475B1
(de)
|
2008-04-02 |
2017-10-04 |
MacroGenics, Inc. |
Bcr-komplex-spezifische antikorper und verfahren zu ihrer verwendung
|
US8802093B2
(en)
|
2008-04-02 |
2014-08-12 |
Macrogenics, Inc. |
HER2/neu-specific antibodies and methods of using same
|
CA2726845C
(en)
*
|
2008-06-04 |
2017-09-26 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
CN102245771B
(zh)
|
2008-12-16 |
2013-04-10 |
诺瓦提斯公司 |
酵母展示系统
|
JP5898082B2
(ja)
|
2009-10-07 |
2016-04-06 |
マクロジェニクス,インコーポレーテッド |
フコシル化程度の変更により改良されたエフェクター機能を示すFc領域含有ポリペプチドおよびその使用法
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
PE20130479A1
(es)
|
2010-03-04 |
2013-05-12 |
Macrogenics Inc |
Anticuerpos reactivos con b7-h3, fragmentos inmulogicamente activos de los mismos y usos de los mismos
|
EP3741883B1
(de)
|
2010-07-16 |
2022-12-14 |
Adimab, LLC |
Antikörperbibliotheken
|
CN103154025B
(zh)
|
2010-08-02 |
2015-07-01 |
宏观基因有限公司 |
共价双抗体及其用途
|
EP2670779B1
(de)
|
2011-02-01 |
2017-08-02 |
Bac Ip B.V. |
Gegen epitope in der ch1-domäne menschlicher igg-antikörper gerichtetes antigenbindendes protein
|
ES2848531T3
(es)
|
2011-05-17 |
2021-08-10 |
Bristol Myers Squibb Co |
Métodos mejorados para la selección de proteínas de unión
|
MX347818B
(es)
|
2011-05-21 |
2017-05-15 |
Macrogenics Inc |
Dominios que enlazan suero desinmunizados y su uso para prolongar la vida media en suero.
|
IN2014CN03936A
(de)
|
2011-10-24 |
2015-09-04 |
Abbvie Inc |
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
US9908938B2
(en)
|
2013-03-14 |
2018-03-06 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
|
UA116479C2
(uk)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
|
US11384149B2
(en)
|
2013-08-09 |
2022-07-12 |
Macrogenics, Inc. |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
|
EP2839842A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische monovalente Diabodies mit Fähigkeit zur Bindung von CD123 und CD3 und Verwendungen davon
|
EP2840091A1
(de)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bispezifische Diabodies, die gpA33 und CD3 binden können und Anwendungen dieser
|
SG11201702544WA
(en)
|
2014-09-29 |
2017-04-27 |
Univ Duke |
Bispecific molecules comprising an hiv-1 envelope targeting arm
|
US11136613B2
(en)
|
2015-04-30 |
2021-10-05 |
Board Of Regents, The University Of Texas System |
Antibacterial polypeptide libraries and methods for screening the same
|
IL262396B2
(en)
|
2016-04-15 |
2023-09-01 |
Macrogenics Inc |
New b7-h3 binding molecules, drug-antibody conjugates and their uses
|
WO2018104893A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
|